scholarly article | Q13442814 |
P356 | DOI | 10.1097/QAD.0000000000000201 |
P698 | PubMed publication ID | 24445368 |
P50 | author | Heinz Wiendl | Q27583547 |
Nicholas Schwab | Q37830514 | ||
Tilman Schneider-Hohendorf | Q48938829 | ||
P2093 | author name string | Ingo W Husstedt | |
Konstanze Philipp | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
P304 | page(s) | 793-795 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Specific loss of cellular L-selectin on CD4(+) T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection | |
P478 | volume | 28 |
Q38268951 | A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy |
Q36942417 | Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy |
Q38367755 | Immunology of progressive multifocal leukoencephalopathy. |
Q36072424 | Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. |
Q48938768 | PML risk stratification using anti-JCV antibody index and L-selectin. |
Q30245002 | Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals. |
Q64040576 | The Progressive Multifocal Leukoencephalopathy Consortium as a Model for Advancing Research and Dialogue on Rare Severe Adverse Drug Reactions |
Q58711606 | The effect of disease modifying therapies on CD62L expression in multiple sclerosis |
Q40928069 | Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values. |
Q38665891 | Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions |
Q85634787 | [Prognostic and predictively relevant factors for multiple sclerosis] |
Search more.